Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Shares | 100.000 | 100.000 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 20.743 | 19.300 |
| Price to Book | 4.794 | 3.740 |
| Price to Sales | 2.438 | 2.180 |
| Price to Cash Flow | 15.295 | 14.523 |
| Dividend Yield | 1.596 | 1.489 |
| 5 Years Earnings Growth | 12.429 | 9.746 |
| Name | Net % | Category Average |
|---|---|---|
| Healthcare | 95.640 | 94.944 |
| Industrials | 2.040 | 2.558 |
| Basic Materials | 1.390 | 1.653 |
| Consumer Defensive | 0.930 | 3.039 |
Number of long holdings: 44
Number of short holdings: 0
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| UnitedHealth | US91324P1021 | 10.36 | 362.50 | +0.57% | |
| Roche Holding Participation | CH0012032048 | 6.97 | 271.20 | -0.15% | |
| Novo Nordisk A/S Class B | DK0060534915 | 6.87 | - | - | |
| Amgen | US0311621009 | 6.18 | 291.76 | -0.39% | |
| Elevance Health | US0367521038 | 5.54 | 342.35 | -1.13% | |
| Vertex | US92532F1003 | 5.01 | 421.39 | -0.29% | |
| Pfizer | US7170811035 | 4.04 | 24.76 | +0.36% | |
| GSK plc | GB00BN7SWP63 | 3.51 | 1,620.00 | -1.61% | |
| Veeva Systems A | US9224751084 | 3.22 | 293.02 | +0.52% | |
| Regeneron Pharma | US75886F1075 | 3.21 | 577.95 | +0.39% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| American Growth Portfolio A Acs | 8.68B | -25.83 | 11.14 | 14.09 | ||
| Thematic Research Portfolio S1X Acs | 1.94B | 10.14 | 21.69 | 12.12 | ||
| Intl Health Care Portfolio A Accs | 4.17B | 23.27 | 20.58 | 15.22 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review